MENU
+Compare
ONC
Stock ticker: NASDAQ
AS OF
Jul 21, 12:33 PM (EDT)
Price
$291.14
Change
-$3.41 (-1.16%)
Capitalization
34.07B

ONC BeOne Medicines Ltd Forecast, Technical & Fundamental Analysis

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales... Show more

Industry: #Biotechnology
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ONC with price predictions
Jul 18, 2025

ONC's Indicator enters downward trend

The Aroon Indicator for ONC entered a downward trend on July 14, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 241 similar instances where the Aroon Indicator formed such a pattern. In of the 241 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ONC broke above its upper Bollinger Band on July 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 14, 2025. You may want to consider a long position or call options on ONC as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ONC just turned positive on July 15, 2025. Looking at past instances where ONC's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

ONC moved above its 50-day moving average on July 09, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ONC crossed bullishly above the 50-day moving average on July 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ONC advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ONC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.107) is normal, around the industry mean (18.143). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). ONC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (7.547) is also within normal values, averaging (270.975).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ONC is expected to report earnings to fall 83.06% to 20 cents per share on August 06

BeOne Medicines Ltd ONC Stock Earnings Reports
Q2'25
Est.
$0.21
Q1'25
Beat
by $1.65
Q4'24
Missed
by $0.42
Q3'24
Beat
by $0.95
The last earnings report on May 07 showed earnings per share of $1.22, beating the estimate of -43 cents. With 41.39K shares outstanding, the current market capitalization sits at 34.07B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JMID29.400.11
+0.38%
Janus Henderson Mid Cap Growth Alpha ETF
SCHH21.330.06
+0.28%
Schwab US REIT ETF™
BBHY46.440.09
+0.19%
JPMorgan BetaBuilders $ HY Corp Bnd ETF
KRBN30.00-0.09
-0.30%
KraneShares Global Carbon ETF
FLLA20.60-0.26
-1.26%
Franklin FTSE Latin America ETF

ONC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
+1.45%
ZLAB - ONC
55%
Loosely correlated
-6.78%
IPSC - ONC
32%
Poorly correlated
+0.10%
RGNX - ONC
31%
Poorly correlated
-6.10%
LEGN - ONC
31%
Poorly correlated
-1.28%
ROIV - ONC
31%
Poorly correlated
-1.80%
More